2seventy bio TSVT Stock
5.04 USD
{{ price }}
-8.695652%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
258.61M USD
LOW - HIGH [24H]
4.96
-
5.5 USD
VOLUME [24H]
797.62K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-4.42 USD
2seventy bio Price Chart
2seventy bio TSVT Financial and Trading Overview
| 2seventy bio stock price | 5.04 USD |
| Previous Close | 10.75 USD |
| Open | 10.72 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1100 |
| Day's Range | 10.48 - 10.83 USD |
| 52 Week Range | 8.25 - 18.88 USD |
| Volume | 914.43K USD |
| Avg. Volume | 827.54K USD |
| Market Cap | 539.14M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 28.17 USD |
TSVT Valuation Measures
| Enterprise Value | 466.67M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.8870966 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.3239164 |
| Price/Book (mrq) | 1.3431716 |
| Enterprise Value/Revenue | 3.743 |
| Enterprise Value/EBITDA | -2.183 |
Trading Information
2seventy bio Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -10.35% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 18.88 USD |
| 52 Week Low | 8.25 USD |
| 50-Day Moving Average | 10.71 USD |
| 200-Day Moving Average | 12.46 USD |
TSVT Share Statistics
| Avg. Volume (3 month) | 827.54K USD |
| Avg. Daily Volume (10-Days) | 834.88K USD |
| Shares Outstanding | 50.2M |
| Float | 44.44M |
| Short Ratio | 9.04 |
| % Held by Insiders | 2.38% |
| % Held by Institutions | 68.44% |
| Shares Short | 7.58M |
| Short % of Float | 15.29% |
| Short % of Shares Outstanding | 15.10% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -172.80% |
| Operating Margin (ttm) | -179.65% |
| Gross Margin | -118.93% |
| EBITDA Margin | -171.42% |
Management Effectiveness
| Return on Assets (ttm) | -17.56% |
| Return on Equity (ttm) | -50.77% |
Income Statement
| Revenue (ttm) | 124.69M USD |
| Revenue Per Share (ttm) | 3.13 USD |
| Quarterly Revenue Growth (yoy) | 393.80% |
| Gross Profit (ttm) | -183458000 USD |
| EBITDA | -213750000 USD |
| Net Income Avi to Common (ttm) | -215463008 USD |
| Diluted EPS (ttm) | -4.42 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 339.93M USD |
| Total Cash Per Share (mrq) | 6.77 USD |
| Total Debt (mrq) | 266.95M USD |
| Total Debt/Equity (mrq) | 66.52 USD |
| Current Ratio (mrq) | 5.067 |
| Book Value Per Share (mrq) | 7.996 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -212740000 USD |
| Levered Free Cash Flow (ttm) | -159870000 USD |
Profile of 2seventy bio
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 60 Binney Street |
| ZIP | 02142 |
| Phone | 339 499 9300 |
| Website | https://www.2seventybio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 425 |
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and chimeric antigen receptor-T cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Q&A For 2seventy bio Stock
What is a current TSVT stock price?
2seventy bio TSVT stock price today per share is 5.04 USD.
How to purchase 2seventy bio stock?
You can buy TSVT shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 2seventy bio?
The stock symbol or ticker of 2seventy bio is TSVT.
Which industry does the 2seventy bio company belong to?
The 2seventy bio industry is Biotechnology.
How many shares does 2seventy bio have in circulation?
The max supply of 2seventy bio shares is 51.31M.
What is 2seventy bio Price to Earnings Ratio (PE Ratio)?
2seventy bio PE Ratio is now.
What was 2seventy bio earnings per share over the trailing 12 months (TTM)?
2seventy bio EPS is -4.42 USD over the trailing 12 months.
Which sector does the 2seventy bio company belong to?
The 2seventy bio sector is Healthcare.
2seventy bio TSVT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}